Ergoferon Increases IL-2 Production by Activated Lymphocytes

M. A. Kanareikina; E. S. Alinkina; A. O. Petrova; A. G. Emel’yanova; E. A. Gorbunov; S. A. Tarasov

doi:10.1007/s10517-019-04431-1

Ergoferon Increases IL-2 Production by Activated Lymphocytes

Авторы: Kanareikina M.¹, Alinkina E.¹, Petrova A.¹, Emel’yanova A.¹, Gorbunov E.¹, Tarasov S.²
Учреждения:
1. Materia Medica Holding Research-and-Production Company, Research Institute of General Pathology and Pathophysiology
2. Laboratory of Physiologically Active Substances, Department of Molecular and Cellular Pathophysiology, Research Institute of General Pathology and Pathophysiology
Выпуск: Том 166, № 6 (2019)
Страницы: 744-746
Раздел: Article
URL: https://journals.rcsi.science/0007-4888/article/view/241330
DOI: https://doi.org/10.1007/s10517-019-04431-1
ID: 241330

Цитировать

Полный текст

Открытый доступ
Доступ закрыт

Доступ предоставлен
Доступ закрыт

Только для подписчиков

Аннотация
Об авторах
Список литературы
Статистика

Аннотация

We studied the effects of Ergoferon on the production of antiviral cytokine IL-2 by type 1 CD4⁺T cells. Preincubation of Jurkat cells with Ergoferon increased IL-2 secretion by these cells after stimulation with phorbol 12-myristate 13-acetate/ionomycine in comparison with the placebo group. The data prove that Ergoferon is capable of activating cell cascades involved in the realization of the antiviral immune response.